Job title: Chief Scientific Officer
Heather Kay Webb Hsu, PhI have over 22 years of pharmaceutical/biotech industry experience with research, nonclinical development and clinical pharmacology of small molecules, peptides and proteins. I have built, participated in and led teams of skilled professionals that have brought multiple drugs from discovery research through to clinical proof of concept.
My PhD from the University of Michigan included a collaboration with both Eli Lilly and Parke Davis Pharmaceuticals. In the years since, I have led research and nonclinical teams in multiple disease indication areas including, but not limited to oncology, inflammatory and cardiometabolic diseases at companies including Johnson and Johnson and Gilead Sciences as well as smaller companies. I am currently the Chief Scientific Officer for Inipharm, a pharmaceutical company focused on discovery of drugs targeting genetically-defined mechanisms for the treatment of chronic liver disease, As a current Pacific Northwesterner, I hike whenever and wherever I can, including urban hiking.